(R)-AS-1   Click here for help

GtoPdb Ligand ID: 12135

Synonyms: (R)-7
Compound class: Synthetic organic
Comment: (R)-AS-1 acts as a positive allosteric modulator (PAM) of the excitatory amino acid transporter, EAAT2 (SLC1A2) that enhances glutamate uptake in vitro [1]. It exhibits potent antiseizure activity in mouse seizure models. (R)-AS-1 is one of the chemical structures that are claimed in patent WO2020214043A1 [2].
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 5
Hydrogen bond donors 1
Rotatable bonds 5
Topological polar surface area 66.48
Molecular weight 260.12
XLogP 0.58
No. Lipinski's rules broken 0
SMILES / InChI / InChIKey
Click here for help
Canonical SMILES C[C@@H](N1C(=O)CCC1=O)C(=O)NCc1ccccc1
Isomeric SMILES O=C(NCc1ccccc1)[C@@H](C)N1C(=O)CCC1=O
InChI InChI=1S/C14H16N2O3/c1-10(16-12(17)7-8-13(16)18)14(19)15-9-11-5-3-2-4-6-11/h2-6,10H,7-9H2,1H3,(H,15,19)/t10-/m1/s1
InChI Key XVSYJYYNUSOPAQ-SNVBAGLBSA-N
References
1. Abram M, Jakubiec M, Reeb K, Cheng MH, Gedschold R, Rapacz A, Mogilski S, Socała K, Nieoczym D, Szafarz M et al.. (2022)
Discovery of (R)-N-Benzyl-2-(2,5-dioxopyrrolidin-1-yl)propanamide [(R)-AS-1], a Novel Orally Bioavailable EAAT2 Modulator with Drug-like Properties and Potent Antiseizure Activity In Vivo.
J Med Chem, 65 (17): 11703-11725. [PMID:35984707]
2. Kaminski K, Abram M, Jakubiec M, Rapacz A, Mogilski S, Latacz G, Struga M. (2020)
Modified amino acid derivatives for the treatment of neurological diseases and selected psychiatric disorders.
Patent number: WO2020214043A1. Assignee: Uniwersytet Jagielloński, Warszawski Uniwersytet Medyczny. Priority date: 16/04/2019. Publication date: 22/10/2020.